Navigation Links
EPGL Medical Invents New Cell Regeneration Technology For Eye Disease

IRVINE, Calif., Aug. 7, 2013 /PRNewswire/ -- EP Global Communications, Inc. and EPGL Medical (the Company), (OTC-PINK: EPGL) announced today that Company engineers have invented a new device for the purpose of treating serious eye diseases such as macular degeneration and retinitis pigmentosa. The technology emits low intensity pulse ultrasound into the eye for the purpose of regeneration of damaged cells and to possibly arrest the degeneration of existing healthy cells within the macula and the entire retina.

"The technology has proven to be very effective in recent research.  We now have the ability to use MEMS to put the technology into the micro size environment for contact lenses.  This technology will be incorporated into therapeutic contact lenses which will emit a low, safe dose of the ultrasound energy into the eye on a regular basis for the purpose of slowing or arresting the development of macular degeneration, retinitis pigmentosa and other eye disorders," said David T. Markus, PhD.  "We want to pioneer the area of therapeutic contact lenses and we can see a tremendous market size and need going into the future for this technology."

On Monday August 12, 2013 EPGL Medical will introduce three more advanced technological devices which is has invented and is currently developing as prototypes and for FDA clearance in the near future.

Facts on Macular Degeneration

Macular degeneration is the second-highest cause of irreversible blindness in the world.  Macular degeneration is a leading cause of vision loss in Americans 60 years of age and older.  The number of people living with macular degeneration today is similar to that of those who have all types of cancer. As many as 11 million people in the United States have some form of age-related macular degeneration. This number is expected to double to nearly 22 million by 2050.  Macular degeneration is expensive, and will only become more expensive as the population aged 65 and older increases.  Estimates of the global cost of visual impairment due to age-related macular degeneration is US$343 billion, including US$255 billion in direct health care costs.

About EP Global Communications, Inc. / EPGL Medical
EP Global Communications, Inc. is a medical device manufacturer and marketing company with a world-class team of doctors and scientists on board.  The Company is currently marketing its first FDA cleared device with several additional "smart" medical devices under development.  The Company is the owner of the cutting edge technological platform for medical device development called "Topspin."



SOURCE EP Global Communications, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Building Stronger Relationships with Key Opinion Leaders Ignites Need for Medical Science Liaisons
2. Implantable Medical Devices Market - U.S. Industry Analysis, Size, Share, Trends, Growth and Forecast, 2012 - 2018
3. FullCircle Registry, Inc. Announces Letter of Intent to Purchase Medical Supply Company
4. Vasomedical to Report Second Quarter 2013 Results on August 13, 2013
5. Volcano Reports Second Quarter Results; Medical Segment Revenues Increase More Than 13 Percent On A Constant Currency Basis
6. Orange County Physician Owned Medical Group Opens Pioneering Medical Facility
7. Early Morning Insight: Baxter, CareFusion, Unilife, and Mindray Medical
8. Medical Power Supply Market by Technology, Type & Application - Forecasts to 2017
9. Philadelphia Business Journal has named Hope Paige Medical ID one of its Best Places to Work in Philadelphia
10. New Strains of Nevil and ReeferMan Medical Marijuana Seeds Now Available Online From R.M.S.S. Medical Marijuana Seed Sales
11. Cardium Reports On New Excellagen Distribution Agreement With AvKARE For Veterans Hospitals And Other Governmental Medical Facilities
Post Your Comments:
(Date:6/24/2016)... 2016  Arkis BioSciences, a leading innovator in ... durable cerebrospinal fluid treatments, today announced it has ... is led by Innova Memphis, followed by Angel ... investors.  Arkis, new financing will accelerate the commercialization ... release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... , June 23, 2016 Research ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, ... (Oral, Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is ... a CAGR of 6.1% in the forecast period 2016 ...
(Date:6/23/2016)... Capricor Therapeutics, Inc. ... company focused on the discovery, development and commercialization ... in its ongoing randomized HOPE-Duchenne clinical trial (Halt ... its 24-patient target. Capricor expects the trial to ... 2016, and to report top line data from ...
Breaking Medicine Technology:
(Date:6/25/2016)... Long Beach, CA (PRWEB) , ... June 25, 2016 , ... ... from UCLA with Magna Cum Laude and his M.D from the David Geffen School ... San Diego and returned to Los Angeles to complete his fellowship in hematology/oncology at ...
(Date:6/25/2016)... ... ... On Friday, June 10, Van Mitchell, Secretary of the Maryland Department of ... recognition of their exemplary accomplishments in worksite health promotion. , The Wellness at Work ... Symposium at the BWI Marriott in Linthicum Heights. iHire was one of 42 businesses ...
(Date:6/24/2016)... ... 2016 , ... A recent article published June 14 on E ... goes on to state that individuals are now more comfortable seeking to undergo not ... as calf and cheek reduction. The Los Angeles area medical group, Beverly Hills Physicians ...
(Date:6/24/2016)... Marne, Michigan (PRWEB) , ... June 24, 2016 , ... ... awareness about the dangers associated with chronic pain and the benefits of holistic treatments, ... for individuals who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) ...
(Date:6/24/2016)... ... 24, 2016 , ... The Pulmonary Hypertension Association (PHA) learned ... receive two significant new grants to support its work to advance research and ... by recognizing patients, medical professionals and scientists for their work in fighting pulmonary ...
Breaking Medicine News(10 mins):